Tech Company Financing Transactions
Lassen Therapeutics Funding Round
Lassen Therapeutics, based in San Diego, secured $85 million in funding from Frazier Life Sciences, Alta Partners and BVF Partners.
Transaction Overview
Company Name
Announced On
12/20/2023
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to Expansion of the Phase 1 study in IPF and TED.Initiation and expansion of the Phase 2 program in TED in the US and ex-US.Development of subcutaneous formulation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5510 Morehouse Dr 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Fardis
Co-Founder
Mark Barrett
Co-Founder
David King
Browse more venture capital transactions:
Prev: 12/20/2023: Tres venture capital transaction
Next: 12/20/2023: Hillhurst Biopharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs